Ontology highlight
ABSTRACT: Background
Macaques are outstanding animal models for the development of new contraceptives. In women, progestin-only contraceptives often fail to block ovulation and are believed to act by altering cervix physiology. Herein, we assessed oviductal glycoprotein 1 (OVGP1) in the macaque cervix as a marker for progestogen action.Materials
Rhesus macaques were treated with estradiol (E2 ), E2 plus progesterone (P), and E2 plus levonorgestrel (LNG), a contraceptive progestin. Samples consisted of archived blocks of midcervix mucosa (epithelium and lamina propria) and fresh epithelial cells collected non-invasively by cytobrush. OVGP1 was assayed by quantitative real-time PCR and localized by immunocytochemistry.Results
OVGP1 transcript was maximal after E2 and reduced after treatment with E2 + P (P < .05). LNG also reduced OVGP1 expression (P < .05). OVGP1-specific staining localized to epithelial cells, and transcript was quantifiable in cytobrush collected samples.Conclusions
OVGP1 expression in cytobrush samples of macaque cervix provides a non-invasive indicator of contraceptive progestin action.
SUBMITTER: Slayden OD
PROVIDER: S-EPMC6234059 | biostudies-literature | 2018 Dec
REPOSITORIES: biostudies-literature

Journal of medical primatology 20180704 6
<h4>Background</h4>Macaques are outstanding animal models for the development of new contraceptives. In women, progestin-only contraceptives often fail to block ovulation and are believed to act by altering cervix physiology. Herein, we assessed oviductal glycoprotein 1 (OVGP1) in the macaque cervix as a marker for progestogen action.<h4>Materials</h4>Rhesus macaques were treated with estradiol (E<sub>2</sub> ), E<sub>2</sub> plus progesterone (P), and E<sub>2</sub> plus levonorgestrel (LNG), a ...[more]